Abiopharma

GEVO, INC. (GEVO)

Symbol	GEVO
Name	GEVO, INC.
Sector	INDUSTRIALS
Region	North America
Industry	Major Chemicals
Address	345 INVERNESS DRIVE SOUTH,BUILDING C, SUITE 310, ENGLEWOOD, Colorado, 80112, United States
Telephone	+1 303 858-8358
Fax	—
Email	—
Website	https://www.gevo.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001392380
Description	Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, Net-Zero Segment and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. Gevo Development/Agri-Energy is the key revenue-generating segment that involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products. Additional info from NASDAQ: Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, Net-Zero Segment and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. Gevo Development/Agri-Energy is the key revenue-generating segment that involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.

2026-08-07 21:22

Director Gruber Patrick R. 🔴 sold 247.6K shares of Gevo, Inc. (GEVO) at $1.51 Transaction Date: Aug 06, 2026 | Filing ID: 054929

2026-08-07 21:22

Bowron Kimberly T 🔴 sold 10.3K shares of Gevo, Inc. (GEVO) at $1.55 Transaction Date: Aug 06, 2026 | Filing ID: 054927

2026-08-07 21:21

Agiri Oluwagbemileke Yusuf 🔴 sold 18.2K shares of Gevo, Inc. (GEVO) at $1.54 Transaction Date: Aug 06, 2026 | Filing ID: 054926

2026-08-07 21:20

Director Bloom Paul D 🔴 sold 31.1K shares of Gevo, Inc. (GEVO) at $1.55 Transaction Date: Aug 06, 2026 | Filing ID: 054925

2026-08-07 10:42

New Form SCHEDULE 13G - Gevo, Inc. Filed: 2026-08-07 AccNo: 0000093751-26-000472 Size: 8 KB

2026-08-06 20:01

Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026

2026-07-22 12:30

Gevo to Report Second Quarter 2026 Financial Results on August 6

2026-07-16 12:36

(99% Positive) GEVO, INC. (GEVO) Files Form 8-K

2026-07-16 12:30

Gevo Announces Appointment of Todd Werpy to Board of Directors

2026-07-15 12:30

Gevo Provides Business Update and Announces Progress on Business Objectives